Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Effects of Chemicals: Overview01:27

Effects of Chemicals: Overview

Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Drug Biotransformation: Overview01:28

Drug Biotransformation: Overview

Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>In Situ</i> Temperature-Dependent Properties of Metal-Organic Framework ZIF-Coated ZnO Hybrid Structures: Structural and Advanced Spectroscopic Insights.

ACS omega·2026
Same author

3D Aerohydrogel Scaffolds for Brain Tissue Engineering and <i>In Vitro</i> Neuroscience.

Chem & bio engineering·2026
Same author

High-Throughput Cardiac Hypertrophy Phenotyping Supports Lead Optimization of GRK5 Inhibitors.

ACS medicinal chemistry letters·2026
Same author

Evaluation of an antibody panel for alpha-synuclein detection in FFPE rectal biopsies in Parkinson's disease.

IBRO neuroscience reports·2025
Same author

Origami-inspired reprogrammable microactuator system.

Microsystems & nanoengineering·2025
Same author

Fluid dynamics model of the cerebral ventricular system.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same journal

Biomechanical Performance of Zirconia-Calcium Silicate-Silver Hybrid Dental Crown Under Static and Transient Dynamic Loading: A Finite Element and TOPSIS-Based Multi-Criteria Evaluation.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same journal

Synthesis, Characterization, and Implantation of Ferulic Acid-Loaded Chitosan/Aloe vera Hydrogels in Rat Full-Thickness Wound Model.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same journal

Double-Crosslinked SIS-Derived Collagen/Alginate Hydrogel With Antibacterial and Pro-Regenerative Activities for Soft Tissue Repair.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same journal

Silver and Gold Nanoparticles Promote Antimicrobial Activity and Modulate Inflammation in Escherichia coli-Infected Wounds.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same journal

Injectable Thermosensitive Placental ECM-Copper Hydrogel With Endothelial Progenitor Cells for Pressure Ulcer Repair.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
Same journal

Strut Thickness and Species-Specific Healing Are Key Considerations in Developing Zinc-Based Biodegradable Arterial Stents.

Journal of biomedical materials research. Part B, Applied biomaterials·2026
See all related articles

Related Experiment Video

Updated: Jun 9, 2026

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration
08:52

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Published on: January 10, 2018

14.8K

Targeting the Glial Scar: Biomaterial and Drug-Based Strategies for Modulation In Vitro.

Luise Schlotterose1,2, Duygu Dengiz3, Meryem G Ersahin3

  • 1Institute of Anatomy, Kiel University, Kiel, Germany.

Journal of Biomedical Materials Research. Part B, Applied Biomaterials
|November 29, 2025
PubMed
Summary
This summary is machine-generated.

This study introduces an in vitro model to test drugs and biomaterials for central nervous system regeneration. The platform assesses glial scar formation, aiding the development of therapeutics and neural implants.

Keywords:
glial scarmaterial‐cell interactionsnitinolshape memory alloyssurface energy and roughnesstransforming growth factor‐β

More Related Videos

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

15.5K
Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

5.7K

Related Experiment Videos

Last Updated: Jun 9, 2026

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration
08:52

Three-dimensional Tissue Engineered Aligned Astrocyte Networks to Recapitulate Developmental Mechanisms and Facilitate Nervous System Regeneration

Published on: January 10, 2018

14.8K
Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation
09:19

Improved 3D Hydrogel Cultures of Primary Glial Cells for In Vitro Modelling of Neuroinflammation

Published on: December 8, 2017

15.5K
Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke
09:41

Injection of Hydrogel Biomaterial Scaffolds to The Brain After Stroke

Published on: October 1, 2020

5.7K

Area of Science:

  • Neuroscience
  • Biomaterials Science
  • Regenerative Medicine

Background:

  • Glial scarring impedes axonal regeneration and neural microelectrode development after central nervous system (CNS) injury.
  • Key characteristics of glial scars include galectin-3 expression and extracellular matrix accumulation.
  • Current methods lack efficient preclinical evaluation of therapeutics and biomaterials for CNS repair.

Purpose of the Study:

  • To establish a human cell line-based in vitro model for evaluating therapeutics and biomaterials targeting glial scar formation.
  • To demonstrate the model's utility in assessing drug targets, specifically transforming growth factor-β receptor types I and II.
  • To integrate biomaterials science by investigating cellular responses to implant materials at the cell-material interface.

Main Methods:

  • Developed a human cell line-based in vitro model mimicking glial scar characteristics.
  • Utilized co-stimulation systems and chemical fabrication techniques to study cell-material interactions.
  • Assessed the impact of nitinol, gold, and platinum surfaces on glial scar-associated gene expression.

Main Results:

  • The in vitro model successfully replicated key glial scar features.
  • The model validated drug targets for reducing glial scar formation by modulating TGF-β receptors.
  • Investigated the effects of various implant materials (nitinol, gold, platinum) on glial scar gene expression.

Conclusions:

  • The developed platform accelerates the validation of drug candidates and optimization of neural implant materials.
  • This approach facilitates the development of strategies for CNS regeneration by mitigating glial scarring.
  • The integrated system supports advancements in both therapeutic development and neural engineering.